What does a notched Q (q wave) on an electrocardiogram (ECG) indicate and how is it managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Notched Q Wave on ECG

A notched Q wave represents fragmented ventricular depolarization, most commonly indicating myocardial scarring from prior infarction, though it has superior sensitivity for detecting myocardial damage compared to traditional pathologic Q waves and requires systematic evaluation to distinguish from normal variants and non-ischemic causes.

Definition and Recognition

A notched Q wave is part of the broader category of fragmented QRS complexes (fQRS), which includes various RSR' patterns, notching in the nadir of the S wave, or multiple R' waves within a QRS duration <120 ms in two contiguous leads corresponding to a major coronary artery territory 1. This differs from traditional pathologic Q waves, which are defined by duration ≥0.03 seconds and depth ≥0.1 mV in two contiguous leads 2.

Clinical Significance

Superior Diagnostic Performance

  • Fragmented QRS (including notched Q waves) demonstrates 85.6% sensitivity for detecting myocardial scar compared to only 36.3% for traditional Q waves alone 1
  • The negative predictive value is 92.7% for fQRS versus 70.8% for Q waves, making notched Q waves a more reliable marker for excluding prior myocardial infarction 1
  • When combined, Q waves and/or fQRS achieve 91.4% sensitivity for detecting myocardial scar 1

Pathophysiologic Implications

  • Notched Q waves indicate altered ventricular depolarization from myocardial scarring, representing areas of non-uniform electrical activation 1
  • They can indicate transmural myocardial infarction with necrosis, typically associated with infarct size >6.2% of left ventricular mass 2
  • Pathologic Q waves (including notched variants) are associated with increased mortality risk, even in "silent" Q-wave MIs 2

Systematic Evaluation Algorithm

Step 1: Verify Technical Factors

  • Check lead placement first to avoid pseudo-septal infarct patterns, as Q waves in V1-V2 commonly result from high lead placement 3
  • Obtain prior ECGs for comparison, as this dramatically improves diagnostic accuracy 3

Step 2: Distinguish Normal from Pathologic

Normal variants that should NOT be considered pathologic:

  • Small septal Q waves <0.03 sec and <25% of R-wave amplitude in leads I, aVL, aVF, and V4-V6 2, 3
  • QS complex in lead V1 2, 3
  • Q wave in lead III <0.03 sec and <25% of R wave amplitude when frontal QRS axis is between 30° and 0° 2, 3
  • Isolated Q waves in lead III without repolarization abnormalities in other inferior leads 3

Step 3: Check for QRS Confounders

These conditions invalidate Q wave interpretation:

  • Left bundle branch block 3
  • Pre-excitation syndromes (WPW) 2
  • Left ventricular hypertrophy 2
  • Hypertrophic cardiomyopathy 3

Step 4: Assess Acuity

Acute versus chronic changes:

  • Q waves with ST-segment elevation ≥0.2 mV in V1-V3 or ≥0.1 mV in other leads suggest acute or evolving infarction 3
  • Measure cardiac biomarkers (troponin) to distinguish acute from chronic changes 3
  • Up to 25% of NSTEMI patients with elevated CK-MB develop Q waves during hospital stay 3
  • Transient Q waves during acute MI may represent severely ischemic but salvageable myocardium, not irreversible damage 4, 5

Step 5: Evaluate for Non-Ischemic Causes

Important differential diagnoses:

  • Hypertrophic cardiomyopathy 3
  • Arrhythmogenic right ventricular cardiomyopathy 3
  • Cardiac amyloidosis 2
  • Infiltrative myocardial diseases 3
  • Myocardial fibrosis without coronary artery disease 2

Management Approach

Immediate Actions

  • Measure cardiac biomarkers (troponin) immediately to determine if this represents acute coronary syndrome 3
  • Perform echocardiography as minimum evaluation to exclude cardiomyopathy and assess wall motion abnormalities 3
  • If acute MI suspected with new Q waves at presentation, recognize this independently predicts increased cardiac mortality (17% vs 7% at long-term follow-up) and warrants aggressive management 6

Risk Stratification

  • New Q waves on presenting ECG independently predict worse outcomes with lower ejection fraction (51% vs 61%), larger end-systolic volume, and increased 30-day cardiac mortality (7% vs 2%) 6
  • Serial ECG monitoring is essential, as when three or more ECGs are obtained, at least two consecutive ECGs should demonstrate the abnormality to confirm evolution 3

Therapeutic Considerations

  • In evolving Q-wave MI, early coronary reperfusion (thrombolysis, angioplasty) may reverse new Q waves if perfusion is restored very early, suggesting myocardial salvage 4, 5
  • Q waves that disappear following thrombolysis represent stunned but viable myocardium rather than irreversibly damaged tissue 4

Critical Pitfalls to Avoid

  • Do not assume all Q waves represent irreversible necrosis - transient Q waves can represent severe ischemia with potentially salvageable myocardium, particularly in the acute setting 5
  • Combining Q waves with other ECG findings (ST-T changes) increases diagnostic accuracy rather than relying on Q waves alone 2
  • Fragmented QRS patterns have substantially higher sensitivity than traditional Q wave criteria and should not be dismissed as insignificant 1
  • Age, new Q waves at presentation, and history of angina are independent predictors of cardiac mortality on multivariate analysis 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.